Evidence map›Paper›PMID 24200678›Full record

ArticleBiochimica et biophysica acta2014

Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation.

D Duval, A Lardeux, T Le Tourneau, R A Norris, R R Markwald, V Sauzeau, V Probst, H Le Marec, R Levine, J J Schott and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Mitral valve disease--morphology and mechanisms.Nature reviews. Cardiology · 2015
    Review
  19. Article
  20. MVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions.Journal of cardiovascular development and disease · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

D DuvalInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: damien.duval@etu.univ-nantes.fr.
A LardeuxInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: aurelie.lardeux@gmail.com.
T Le TourneauInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: thletourneau@yahoo.fr.
R A NorrisDepartment of Regenerative Medicine and Cell Biology, Cardiovascular Developmental Biology Center, Children's Research Institute, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA. Electronic address: norrisra@musc.edu.
R R MarkwaldDepartment of Regenerative Medicine and Cell Biology, Cardiovascular Developmental Biology Center, Children's Research Institute, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA. Electronic address: markwald@musc.edu.
V SauzeauInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: vincent.sauzeau@inserm.fr.
V ProbstInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: vincent.probst@chu-nantes.fr.
H Le MarecInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: herve.lemarec@univ-nantes.fr.
R LevineNoninvasive Cardiac Laboratory, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: RLEVINE@PARTNERS.ORG.
J J SchottInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: jjschott@univ-nantes.fr.
J MerotInstitut du Thorax, INSERM UMR1087, CNRS UMR 6291, 8 Quai Moncousu 44007 Nantes Cedex, France. Electronic address: jean.merot@univ-nantes.fr.
Centre National de la Recherche Scientifique · FRMedical University of South Carolina · USMassachusetts General Hospital · US

Funding

Targeted Nano-therapeutics for Neural RegenerationP20GM103444 · NIGMS · CLEMSON UNIVERSITY · PI SIMIONESCU, AGNETA · 2012 to 2018
$14.9M
SC COBRE for Developmentally Based Cardiovascular DiseasesP30GM103342 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 2012 to 2016
$5.5M
MUCOPOLYSACCHRIDE METABOLISM IN CARDIAC ANOMALIESR01HL033756 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 1985 to 2015
$4.8M
Improving Mitral Compensation in Ischemic RegurgitationR01HL109506 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI AIKAWA, ELENA, BISCHOFF, JOYCE E. · 2012 to 2015
$3.3M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR018823 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2003 to 2003
$2.9M
ISCHEMIC MITRAL REGURGITATION: FROM MECHANISM TO THERAPYK24HL067434 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LEVINE, ROBERT A · 2001 to 2011
$1.6M
NCRR NIH HHS C06 RR018823NHLBI NIH HHS HL109506NHLBI NIH HHS K24 HL067434NHLBI NIH HHS K24 HL67434NHLBI NIH HHS R01 HL033756NHLBI NIH HHS R01 HL109506NHLBI NIH HHS R01-HL33756NIGMS NIH HHS 1 P30 GM103342NIGMS NIH HHS 8P20 GM103444NIGMS NIH HHS P20 GM103444NIGMS NIH HHS P30 GM103342
6 · The paper itself

Abstract

Filamin A (FlnA) is a ubiquitous actin binding protein which anchors various transmembrane proteins to the cell cytoskeleton and provides a scaffold to many cytoplasmic signaling proteins involved in actin cytoskeleton remodeling in response to mechanical stress and cytokines stimulation. Although the vast majority of FlnA binding partners interact with the carboxy-terminal immunoglobulin like (Igl) repeats of FlnA, little is known on the role of the amino-N-terminal repeats. Here, using cardiac mitral valvular dystrophy associated FlnA-G288R and P637Q mutations located in the N-terminal Igl repeat 1 and 4 respectively as a model, we identified a new role of FlnA N-terminal repeats in small Rho-GTPases regulation. Using FlnA-deficient melanoma and HT1080 cell lines as expression systems we showed that FlnA mutations reduce cell spreading and migration capacities. Furthermore, we defined a signaling network in which FlnA mutations alter the balance between RhoA and Rac1 GTPases activities in favor of RhoA and provided evidences for a role of the Rac1 specific GTPase activating protein FilGAP in this process. Together our work ascribed a new role to the N-terminal repeats of FlnA in Small GTPases regulation and supports a conceptual framework for the role of FlnA mutations in cardiac valve diseases centered around signaling molecules regulating cellular actin cytoskeleton in response to mechanical stress.

Indexed as

Repetitive Sequences, Amino AcidCell AdhesionCell Line, TumorCell MovementCell ShapeCell SizeFilaminsGTPase-Activating ProteinsHeart Valve DiseasesHumansMesodermMutant ProteinsMutationrac GTP-Binding ProteinsrhoA GTP-Binding ProteinStructure-Activity RelationshipFilaminsGTPase-Activating ProteinsMutant Proteinsrac GTP-Binding ProteinsrhoA GTP-Binding ProteinFilamin AFilGAPMitral valve prolapseRac1RhoA

Identifiers

PMID24200678
PMCPMC3928473
OpenAlexW1994846158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.